NEW YORK (GenomeWeb) – Oxford Gene Technology today announced it will direct customers using its next-generation sequencing (NGS) services to genomic services firm Source BioScience.

OGT will receive a commission from Source BioScience on any referrals or transferred orders. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.